A detailed history of Reap Financial Group, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Reap Financial Group, LLC holds 134 shares of NVO stock, worth $11,955. This represents 0.0% of its overall portfolio holdings.

Number of Shares
134
Previous 133 0.75%
Holding current value
$11,955
Previous $15.9 Million 27.66%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 27, 2025

BUY
$85.0 - $120.04 $85 - $120
1 Added 0.75%
134 $11.5 Million
Q2 2024

Feb 27, 2025

BUY
$122.71 - $146.91 $122 - $146
1 Added 0.76%
133 $19 Million
Q4 2023

Feb 27, 2025

BUY
$87.78 - $105.45 $11,586 - $13,919
132 New
132 $13.7 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $201B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Reap Financial Group, LLC Portfolio

Follow Reap Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Reap Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Reap Financial Group, LLC with notifications on news.